Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Metagenomi Therapeutics, Inc.
| Metric | Metagenomi Therapeutics, Inc. MGXHealthcare |
|---|---|
| Quality Score | 28 / 100 |
| Revenue (latest) | $25M |
| Net income (latest) | −$88M |
| Operating margin | −380.9% |
| Net margin | −348.5% |
| Return on equity | −55.4% |
| Return on assets | −39.7% |
| Return on capital (ROCE) | −48.4% |
| Debt / equity | 0.39× |
| Revenue growth (YoY) | −51.8% |
| Altman Z″ (distress) | -0.61 |
| Accruals / assets | 0.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.